Table of Content

1 INTRODUCTION 28
1.1 STUDY OBJECTIVES 28
1.2 MARKET DEFINITION 28
1.2.1 INCLUSIONS AND EXCLUSIONS 29
1.3 STUDY SCOPE 30
FIGURE 1 MARKETS COVERED 30
1.3.1 GEOGRAPHIC SCOPE 30
1.3.2 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 31
1.5 STAKEHOLDERS 31
1.6 SUMMARY OF CHANGES 32
1.7 RECESSION IMPACT 32
2 RESEARCH METHODOLOGY 33
2.1 RESEARCH DATA 33
FIGURE 2 RESEARCH DESIGN 33
2.1.1 SECONDARY DATA 34
2.1.2 PRIMARY RESEARCH 35
2.1.2.1 Key data from primary sources 35
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 36
FIGURE 4 DEFIBRILLATORS MARKET: BREAKDOWN OF PRIMARIES 36
2.2 MARKET SIZE ESTIMATION METHODOLOGY 36
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 37
2.2.1 PRODUCT-BASED MARKET ESTIMATION 38
2.2.2 END USER-BASED MARKET ESTIMATION 38
FIGURE 6 DEFIBRILLATORS MARKET: MARKET SIZE ESTIMATION 38
2.2.3 PRIMARY RESEARCH VALIDATION 39
2.3 DATA TRIANGULATION 40
FIGURE 7 DATA TRIANGULATION METHODOLOGY 40
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 41
2.4.1 RESEARCH ASSUMPTIONS 41
2.4.2 RESEARCH LIMITATIONS 41
2.5 RECESSION IMPACT 42
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 42
3 EXECUTIVE SUMMARY 43
FIGURE 8 DEFIBRILLATORS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 43
FIGURE 9 DEFIBRILLATORS MARKET, BY END USER, 2023 VS. 2028 44
FIGURE 10 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2023 VS. 2028 44
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DEFIBRILLATORS MARKET 45
4 PREMIUM INSIGHTS 46
4.1 DEFIBRILLATORS MARKET OVERVIEW 46
FIGURE 12 RISING INCIDENCE OF CVD TO DRIVE MARKET 46
4.2 DEFIBRILLATORS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 47
FIGURE 13 IMPLANTABLE DEFIBRILLATORS TO DOMINATE MARKET DURING FORECAST PERIOD 47
4.3 DEFIBRILLATORS MARKET, BY REGION AND END USER 48
FIGURE 14 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT IN ASIA PACIFIC REGION ACCOUNTED FOR LARGEST SHARE IN 2022 48
4.4 GEOGRAPHIC SNAPSHOT OF DEFIBRILLATORS MARKET 49
FIGURE 15 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
FIGURE 16 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
5.2.1 DRIVERS 51
5.2.1.1 Rising prevalence of cardiovascular diseases 51
TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS, BY REGION 51
5.2.1.2 Growing focus on providing public-access defibrillators 52
5.2.1.3 Training and awareness programs on defibrillators 52
5.2.2 RESTRAINTS 53
5.2.2.1 Frequent product recalls 53
TABLE 3 RECENT PRODUCT RECALLS BY US FDA (2018–2023) 53
5.2.3 OPPORTUNITIES 54
5.2.3.1 Emerging markets 54
5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds 54
5.2.4 CHALLENGES 55
5.2.4.1 Inadequate awareness of sudden cardiac arrests in emerging markets 55
5.2.4.2 Challenges associated with pricing pressure 55
5.3 REIMBURSEMENT SCENARIO 55
TABLE 4 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN US 56
TABLE 5 MEDICARE OUTPATIENT: NATIONAL AVERAGE PAYMENT IN US (2023) 57
5.4 REGULATORY LANDSCAPE 57
5.4.1 US 57
TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION 58
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 58
5.4.1.1 Canada 58
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 59
5.4.2 EUROPE 59
5.4.3 ASIA PACIFIC 60
5.4.3.1 China 60
5.4.3.2 Japan 60
5.4.3.3 India 60
TABLE 9 KEY REGULATORY BODIES AND GOVERNMENT AGENCIES 61
5.5 PRICING TREND ANALYSIS 62
TABLE 10 AVERAGE SELLING PRICE OF DEFIBRILLATORS, BY KEY PLAYER (2021) (USD) 62
TABLE 11 AVERAGE SELLING PRICE OF DEFIBRILLATORS, BY COUNTRY (USD) (2021) 62
5.6 PATENT ANALYSIS 63
FIGURE 17 TOP PATENT APPLICANTS FOR DEFIBRILLATORS DEVICES, JANUARY 2012–MAY 2023 63
5.7 VALUE CHAIN ANALYSIS 64
5.7.1 RESEARCH & DEVELOPMENT 64
5.7.2 MANUFACTURING & ASSEMBLY 64
5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 64
FIGURE 18 DEFIBRILLATORS MARKET: VALUE CHAIN ANALYSIS 64
5.8 SUPPLY CHAIN ANALYSIS 65
FIGURE 19 DEFIBRILLATORS MARKET: SUPPLY CHAIN ANALYSIS 65
5.9 PORTER’S FIVE FORCES ANALYSIS 66
5.9.1 OVERVIEW 66
TABLE 12 DEFIBRILLATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 66
5.9.2 THREAT OF NEW ENTRANTS 66
5.9.3 THREAT OF SUBSTITUTES 66
5.9.4 BARGAINING POWER OF SUPPLIERS 67
5.9.5 BARGAINING POWER OF BUYERS 67
5.9.6 INTENSITY OF COMPETITIVE RIVALRY 67
5.10 TRADE ANALYSIS 67
TABLE 13 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION) 67
TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION) 68
5.11 TECHNOLOGY ANALYSIS 68
FIGURE 20 ECOSYSTEM COVERAGE 69
5.12 KEY CONFERENCES AND EVENTS 69
TABLE 15 DEFIBRILLATORS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2022?2023) 69
5.13 CASE STUDY ANALYSIS 70
5.13.1 IDENTIFY IMPACT OF 4-LAYER RIGID-FLEX BOARD PCB IN DEFIBRILLATORS 70
TABLE 16 CASE 1: IDENTIFY IMPACT OF THIN-LAYERED PCBS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 70
?
5.14 STAKEHOLDERS AND BUYING CRITERIA 71
5.14.1 KEY STAKEHOLDERS 71
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCTS 71
5.15 KEY BUYING CRITERIA 71
FIGURE 22 KEY BUYING CRITERIA FOR DEFIBRILLATORS 71
6 DEFIBRILLATORS MARKET, BY PRODUCT 72
6.1 INTRODUCTION 73
TABLE 17 DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 73
6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 73
TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 74
TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 74
TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION) 74
TABLE 21 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 75
6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 75
TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 76
TABLE 23 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 76
6.2.1.1 Biventricular ICDs/Cardiac resynchronization therapy defibrillators 77
6.2.1.1.1 Launch of technologically advanced CRT-D devices to drive market 77
TABLE 24 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 77
6.2.1.2 Dual-chamber ICDs 78
6.2.1.2.1 Ability to reduce incidence of inappropriate shocks to drive market 78
TABLE 25 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 78
6.2.1.3 Single-chamber ICDs 78
6.2.1.3.1 Utilization in arterial monitoring to support market growth 78
TABLE 26 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 79
6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 79
6.2.2.1 Benefits of eliminating cardiac leads to drive market 79
TABLE 27 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 80
6.3 EXTERNAL DEFIBRILLATORS 80
TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 80
TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION) 81
TABLE 31 EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 81
6.3.1 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS 82
6.3.1.1 Initiatives for emergency medical services to support market growth 82
TABLE 32 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 82
6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS 83
6.3.2.1 Rising installation in public places to propel market 83
TABLE 33 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 83
6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS 84
6.3.3.1 Operational difficulties and false alarms to restrain market adoption 84
TABLE 34 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 84
7 DEFIBRILLATORS MARKET, BY PATIENT TYPE 85
7.1 INTRODUCTION 86
TABLE 35 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION) 86
7.2 ADULT PATIENTS 86
7.2.1 INCREASING UTILIZATION OF PUBLIC-ACCESS DEFIBRILLATORS TO DRIVE MARKET 86
TABLE 36 DEFIBRILLATORS MARKET FOR ADULT PATIENTS, BY REGION, 2021–2028 (USD MILLION) 87
7.3 PEDIATRIC PATIENTS 87
7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO SUPPORT MARKET GROWTH 87
TABLE 37 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2021–2028 (USD MILLION) 88
8 DEFIBRILLATORS MARKET, BY END USER 89
8.1 INTRODUCTION 90
TABLE 38 DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 90
8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS 90
8.2.1 HIGH VOLUME OF ICD PROCEDURES TO DRIVE MARKET 90
TABLE 39 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2021–2028 (USD MILLION) 91
8.3 PREHOSPITAL SETTINGS 91
8.3.1 RISING FUNDING FOR EMERGENCY AMBULANCE SERVICES TO DRIVE MARKET 91
TABLE 40 DEFIBRILLATORS MARKET FOR PREHOSPITAL SETTINGS, BY REGION, 2021–2028 (USD MILLION) 92
8.4 PUBLIC-ACCESS MARKETS 92
8.4.1 RISING INCIDENCE OF SUDDEN CARDIAC ARRESTS TO PROPEL MARKET 92
TABLE 41 DEFIBRILLATORS MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2021–2028 (USD MILLION) 93
8.5 HOME CARE SETTINGS 93
8.5.1 RISING ADOPTION OF HOME-AUTOMATED EXTERNAL DEFIBRILLATORS TO DRIVE MARKET 93
TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021–2028 (USD MILLION) 94
8.6 ALTERNATE CARE FACILITIES 94
8.6.1 INADEQUATE HEALTHCARE INFRASTRUCTURE TO LIMIT ADOPTION 94
TABLE 43 DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2021–2028 (USD MILLION) 94
8.7 OTHER END USERS 95
TABLE 44 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 95
9 DEFIBRILLATORS MARKET, BY REGION 96
9.1 INTRODUCTION 97
TABLE 45 DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION) 97
9.2 NORTH AMERICA 97
FIGURE 23 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT 98
TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 47 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 99
TABLE 48 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 49 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 50 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 100
TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION) 100
TABLE 52 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 100
9.2.1 US 101
9.2.1.1 High implant rates of ICDS to drive market 101
TABLE 53 US: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 101
TABLE 54 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
TABLE 55 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
TABLE 56 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
9.2.2 CANADA 103
9.2.2.1 High burden of CVDs to support market growth 103
TABLE 57 CANADA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 103
TABLE 58 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
TABLE 59 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
TABLE 60 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
9.2.3 NORTH AMERICA: RECESSION IMPACT 105
9.3 EUROPE 105
TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
TABLE 62 EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 105
TABLE 63 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 64 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 65 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION) 107
TABLE 67 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 107
9.3.1 GERMANY 107
9.3.1.1 Established healthcare system equipped with advanced cardiology devices to drive market 107
TABLE 68 GERMANY: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 108
TABLE 69 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 70 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 109
TABLE 71 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 109
9.3.2 UK 109
9.3.2.1 Rising support from government & private organizations for accessibility of defibrillators to drive market 109
TABLE 72 UK: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 110
TABLE 73 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
TABLE 74 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 USD MILLION) 111
TABLE 75 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
9.3.3 FRANCE 111
9.3.3.1 Favorable government initiatives to support market growth 111
TABLE 76 FRANCE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 112
TABLE 77 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 78 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 79 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
9.3.4 ITALY 113
9.3.4.1 High prevalence of OHCA to drive market 113
TABLE 80 ITALY: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 113
TABLE 81 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 82 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 83 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
9.3.5 SPAIN 115
9.3.5.1 Rising awareness initiatives on defibrillators to propel market 115
TABLE 84 SPAIN: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 115
TABLE 85 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 86 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 87 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
9.3.6 REST OF EUROPE 116
TABLE 88 REST OF EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 117
TABLE 89 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 90 REST OF EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 91 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
9.3.7 EUROPE: RECESSION IMPACT 118
9.4 ASIA PACIFIC 118
FIGURE 24 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT 119
TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
TABLE 93 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 120
TABLE 94 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 95 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 96 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION) 121
TABLE 98 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 122
9.4.1 JAPAN 122
9.4.1.1 Presence of universal insurance scheme in Japan to support market growth 122
TABLE 99 JAPAN: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 122
TABLE 100 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 101 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
TABLE 102 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 123
9.4.2 CHINA 124
9.4.2.1 Rising incidence of strokes to drive market 124
TABLE 103 CHINA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 124
TABLE 104 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 105 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 106 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
9.4.3 INDIA 126
9.4.3.1 Growing acceptance of defibrillators and innovative product launches to drive market 126
TABLE 107 INDIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 126
TABLE 108 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 109 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 110 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
9.4.4 AUSTRALIA 128
9.4.4.1 Initiatives by government & private bodies for installation of PADs to support market growth 128
TABLE 111 AUSTRALIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 128
TABLE 112 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 113 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 114 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
9.4.5 SOUTH KOREA 130
9.4.5.1 Launch of innovative products by local players to propel market 130
TABLE 115 SOUTH KOREA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 130
TABLE 116 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 117 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
TABLE 118 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 131
9.4.6 REST OF ASIA PACIFIC (ROAPAC) 131
TABLE 119 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 132
TABLE 120 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 121 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 122 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
9.4.7 ASIA PACIFIC: RECESSION IMPACT 133
9.5 LATIN AMERICA 133
TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
TABLE 124 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 134
TABLE 125 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 134
TABLE 126 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 127 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION) 135
TABLE 129 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 136
9.5.1 BRAZIL 136
9.5.1.1 Increasing obesity cases to support market growth 136
TABLE 130 BRAZIL: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 136
TABLE 131 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 132 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 133 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
9.5.2 MEXICO 138
9.5.2.1 High prevalence of target diseases to support market growth 138
TABLE 134 MEXICO: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 138
TABLE 135 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 136 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 137 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
9.5.3 REST OF LATIN AMERICA 139
TABLE 138 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 140
TABLE 139 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 140 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 141 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 141
9.5.4 LATIN AMERICA: RECESSION IMPACT 141
9.6 MIDDLE EAST & AFRICA 141
9.6.1 GROWING AWARENESS INITIATIVES ON ADVANTAGES OF DEFIBRILLATORS TO SUPPORT MARKET GROWTH 141
TABLE 142 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 142
TABLE 143 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 144 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 145 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION) 143
TABLE 147 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION) 143
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 144
10 COMPETITIVE LANDSCAPE 145
10.1 INTRODUCTION 145
10.1.1 STRATEGIES ADOPTED BY KEY PLAYERS 145
TABLE 148 STRATEGIES ADOPTED BY KEY PLAYERS (2019?2023) 145
10.2 REVENUE SHARE ANALYSIS 146
FIGURE 25 DEFIBRILLATORS MARKET: REVENUE SHARE ANALYSIS OF PLAYERS 147
10.3 MARKET SHARE ANALYSIS 147
FIGURE 26 DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER (2022) 147
TABLE 149 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICD) MARKET: INTENSITY OF COMPETITIVE RIVALRY 148
TABLE 150 AUTOMATED DEFIBRILLATORS MARKET: INTENSITY OF COMPETITIVE RIVALRY 148
10.4 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX (2022) 149
10.4.1 STARS 150
10.4.2 EMERGING LEADERS 150
10.4.3 PERVASIVE PLAYERS 150
10.4.4 PARTICIPANTS 150
FIGURE 27 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX (2022) 151
10.5 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 151
10.5.1 PROGRESSIVE COMPANIES 151
10.5.2 RESPONSIVE COMPANIES 152
10.5.3 DYNAMIC COMPANIES 152
10.5.4 STARTING BLOCKS 152
FIGURE 28 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS (2022) 152
10.6 COMPETITIVE BENCHMARKING: FOOTPRINT ANALYSIS OF LEADING PLAYERS 153
TABLE 151 DEFIBRILLATORS MARKET: COMPANY FOOTPRINT ANALYSIS 153
TABLE 152 DEFIBRILLATORS MARKET: PRODUCT FOOTPRINT ANALYSIS 154
TABLE 153 DEFIBRILLATORS MARKET: REGIONAL FOOTPRINT ANALYSIS 155
10.6.1 PRODUCT LAUNCHES & APPROVALS 156
TABLE 154 DEFIBRILLATORS MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2019–APRIL 2023) 156
10.6.2 DEALS 157
TABLE 155 DEFIBRILLATORS MARKET: KEY DEALS (JANUARY 2019–APRIL 2023) 157
10.6.3 OTHER DEVELOPMENTS 158
TABLE 156 DEFIBRILLATORS MARKET: OTHER DEVELOPMENTS (JANUARY 2019–APRIL 2023) 158
11 COMPANY PROFILES 159
11.1 KEY PLAYERS 159
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1.1 MEDTRONIC 159
TABLE 157 MEDTRONIC: BUSINESS OVERVIEW 159
FIGURE 29 MEDTRONIC: COMPANY SNAPSHOT (2022) 160
11.1.2 STRYKER 165
TABLE 158 STRYKER: BUSINESS OVERVIEW 165
FIGURE 30 STRYKER: COMPANY SNAPSHOT (2022) 166
11.1.3 KONINKLIJKE PHILIPS N.V. 168
TABLE 159 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 168
FIGURE 31 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 169
11.1.4 ASAHI KASEI CORPORATION 172
TABLE 160 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 172
FIGURE 32 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022) 173
11.1.5 BOSTON SCIENTIFIC CORPORATION 175
TABLE 161 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 175
FIGURE 33 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 176
11.1.6 ABBOTT 179
TABLE 162 ABBOTT: BUSINESS OVERVIEW 179
FIGURE 34 ABBOTT: COMPANY SNAPSHOT (2022) 180
TABLE 163 PRODUCT APPROVALS 181
11.1.7 MICROPORT SCIENTIFIC CORPORATION 182
TABLE 164 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 182
FIGURE 35 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022) 183
TABLE 165 PRODUCT APPROVALS 184
11.1.8 NIHON KOHDEN CORPORATION 186
TABLE 166 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 186
FIGURE 36 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022) 187
11.1.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. 189
TABLE 167 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: BUSINESS OVERVIEW 189
FIGURE 37 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021) 190
TABLE 168 PRODUCT LAUNCHES & APPROVALS 191
11.1.10 BIOTRONIK 192
TABLE 169 BIOTRONIK: BUSINESS OVERVIEW 192
11.1.11 CU MEDICAL SYSTEMS CO., LTD. 194
TABLE 170 CU MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW 194
11.1.12 METSIS MEDIKAL LTD. 195
TABLE 171 METSIS MEDIKAL LTD: BUSINESS OVERVIEW 195
11.1.13 MEDIANA CO. LTD. 196
TABLE 172 MEDIANA CO. LTD.: BUSINESS OVERVIEW 196
11.1.14 PROGETTI SRL 198
TABLE 173 PROGETTI SRL: BUSINESS OVERVIEW 198
11.1.15 SCHILLER AG 199
TABLE 174 SCHILLER AG: BUSINESS OVERVIEW 199
11.1.16 BPL MEDICAL TECHNOLOGIES 201
TABLE 175 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 201
11.1.17 METRAX GMBH 202
TABLE 176 METRAX GMBH: BUSINESS OVERVIEW 202
11.1.18 MS WESTFALIA GMBH 203
TABLE 177 MS WESTFALIA GMBH: BUSINESS OVERVIEW 203
11.1.19 BEXEN CARDIO 204
TABLE 178 BEXEN CARDIO: BUSINESS OVERVIEW 204
11.1.20 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD. 206
TABLE 179 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW 206
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 207
11.2.1 AVIVE SOLUTIONS INC. 207
11.2.2 AMI ITALIA 207
11.2.3 CORPULS 208
11.2.4 ALLIED MEDICAL LTD. 208
11.2.5 AXION CONCERN LLC 209
12 APPENDIX 210
12.1 DISCUSSION GUIDE 210
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 214
12.3 CUSTOMIZATION OPTIONS 216
12.4 RELATED REPORTS 216
12.5 AUTHOR DETAILS 217